BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36514219)

  • 1. KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H
    Fan K; Zhang S; Ni X; Shen S; Wang J; Sun W; Suo T; Liu H; Ni X; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2022 Nov; 54(11):1731-1739. PubMed ID: 36514219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
    DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
    Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy.
    Ferino A; Rapozzi V; Xodo LE
    J Photochem Photobiol B; 2020 Jan; 202():111672. PubMed ID: 31778952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
    Yang H; Xiang S; Kazi A; Sebti SM
    J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
    Müller F; Lim JKM; Bebber CM; Seidel E; Tishina S; Dahlhaus A; Stroh J; Beck J; Yapici FI; Nakayama K; Torres Fernández L; Brägelmann J; Leprivier G; von Karstedt S
    Cell Death Differ; 2023 Feb; 30(2):442-456. PubMed ID: 36443441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
    Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
    Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition.
    Hamada S; Matsumoto R; Tanaka Y; Taguchi K; Yamamoto M; Masamune A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRas, ROS and the initiation of pancreatic cancer.
    Storz P
    Small GTPases; 2017 Jan; 8(1):38-42. PubMed ID: 27215184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor-BB induces cystathionine γ-lyase expression in rat mesangial cells via a redox-dependent mechanism.
    Hassan MI; Boosen M; Schaefer L; Kozlowska J; Eisel F; von Knethen A; Beck M; Hemeida RA; El-Moselhy MA; Hamada FM; Beck KF; Pfeilschifter J
    Br J Pharmacol; 2012 Aug; 166(8):2231-42. PubMed ID: 22428706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kras
    Cheng H; Fan K; Luo G; Fan Z; Yang C; Huang Q; Jin K; Xu J; Yu X; Liu C
    Cancer Lett; 2019 Apr; 446():103-111. PubMed ID: 30664964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
    Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
    Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
    Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
    Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis.
    Xie CM; Wei D; Zhao L; Marchetto S; Mei L; Borg JP; Sun Y
    J Cell Biol; 2015 Jun; 209(5):721-37. PubMed ID: 26056141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous cystathionine-gamma-lyase/hydrogen sulfide pathway regulates apoptosis of HepG2 cells.
    Wang TX; Shi XY; Liu YH
    Yao Xue Xue Bao; 2013 Aug; 48(8):1233-40. PubMed ID: 24187829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild‑type KRAS inhibits the migration and invasion of pancreatic cancer through the Wnt/β‑catenin pathway.
    Hu X; Zhang R; Yao J; Mu B; Zhao C
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36367161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological insights in non-small cell lung cancer.
    Rosell R; Jain A; Codony-Servat J; Jantus-Lewintre E; Morrison B; Ginesta JB; González-Cao M
    Cancer Biol Med; 2023 Jun; 20(7):500-18. PubMed ID: 37381723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
    Yang H; Mao Y; Tan B; Luo S; Zhu Y
    Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Lethality of a Novel Small Molecule Against Mutant KRAS-Expressing Cancer Cells Involves AKT-Dependent ROS Production.
    Iskandar K; Rezlan M; Yadav SK; Foo CH; Sethi G; Qiang Y; Bellot GL; Pervaiz S
    Antioxid Redox Signal; 2016 May; 24(14):781-94. PubMed ID: 26714745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair.
    Yang L; Shen C; Estrada-Bernal A; Robb R; Chatterjee M; Sebastian N; Webb A; Mo X; Chen W; Krishnan S; Williams TM
    Nucleic Acids Res; 2021 Nov; 49(19):11067-11082. PubMed ID: 34606602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.